246 related articles for article (PubMed ID: 31423947)
21. Implementation of an antimicrobial stewardship program for patients with febrile neutropenia.
Madran B; Keske Ş; Tokça G; Dönmez E; Ferhanoğlu B; Çetiner M; Mandel NM; Ergönül Ö
Am J Infect Control; 2018 Apr; 46(4):420-424. PubMed ID: 29174192
[TBL] [Abstract][Full Text] [Related]
22. A de-escalation protocol for febrile neutropenia cases and its impact on carbapenem resistance: A retrospective, quasi-experimental single-center study.
Alshukairi A; Alserehi H; El-Saed A; Kelta M; Rehman JU; Khan FA; Alsalmi H; Alattas M; Aslam M
J Infect Public Health; 2016; 9(4):443-51. PubMed ID: 26688375
[TBL] [Abstract][Full Text] [Related]
23. Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation.
Kamboj M; Cohen N; Huang YT; Kerpelev M; Jakubowski A; Sepkowitz KA; Papanicolaou GA; Seo SK
Biol Blood Marrow Transplant; 2019 Mar; 25(3):594-598. PubMed ID: 30448456
[TBL] [Abstract][Full Text] [Related]
24. The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).
Perreault S; McManus D; Bar N; Foss F; Gowda L; Isufi I; Seropian S; Malinis M; Topal JE
Transpl Infect Dis; 2019 Apr; 21(2):e13059. PubMed ID: 30737868
[TBL] [Abstract][Full Text] [Related]
25. Examining the Evidence for Escalating Antimicrobial Regimens in Febrile Oncology and Hematopoietic Stem Cell Transplant Patients Admitted to the PICU: An Observational Study.
Prince RD; Blumenthal JA; Geva A
Pediatr Crit Care Med; 2023 Jun; 24(6):e292-e296. PubMed ID: 37036203
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
27. Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp.
Lisboa LF; Miranda BG; Vieira MB; Dulley FL; Fonseca GG; Guimarães T; Levin AS; Shikanai-Yasuda MA; Costa SF
Int J Infect Dis; 2015 Apr; 33():171-6. PubMed ID: 25660090
[TBL] [Abstract][Full Text] [Related]
28. Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.
Owattanapanich W; Suphadirekkul K; Kunacheewa C; Ungprasert P; Prayongratana K
BMC Cancer; 2018 Nov; 18(1):1126. PubMed ID: 30445930
[TBL] [Abstract][Full Text] [Related]
29. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
[TBL] [Abstract][Full Text] [Related]
30. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial stewardship in high-risk febrile neutropenia patients.
Contejean A; Abbara S; Chentouh R; Alviset S; Grignano E; Gastli N; Casetta A; Willems L; Canouï E; Charlier C; Pène F; Charpentier J; Reboul-Marty J; Batista R; Bouscary D; Kernéis S
Antimicrob Resist Infect Control; 2022 Mar; 11(1):52. PubMed ID: 35346373
[TBL] [Abstract][Full Text] [Related]
32. Early de-escalation of antibiotic therapy in hospitalized cellular therapy adult patients with febrile neutropenia.
Lucena M; Gaffney KJ; Urban T; Forbes C; Srinivas P; Majhail NS; Cober E; Mossad SB; Rybicki L; Hamilton BK
Clin Hematol Int; 2024; 6(1):59-66. PubMed ID: 38817693
[TBL] [Abstract][Full Text] [Related]
33. [Antimicrobial therapy in cancer patients and hematopoietic stem cell transplantation receptors].
Santolaya ME; Álvarez AM; Bidart T; Morales J; González C
Rev Chilena Infectol; 2019 Apr; 36(2):167-178. PubMed ID: 31344153
[TBL] [Abstract][Full Text] [Related]
34. Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH; Schoettler ML; Spencer K; Stenger E; Watkins B; Williams KM; Leung K; Jaggi P; Qayed M
Transplant Cell Ther; 2023 Dec; 29(12):778.e1-778.e6. PubMed ID: 37739225
[TBL] [Abstract][Full Text] [Related]
35. Current antimicrobial practice in febrile neutropenia across Europe and Asia: the EBMT Infectious Disease Working Party survey.
Verlinden A; Mikulska M; Knelange NS; Averbuch D; Styczynski J;
Bone Marrow Transplant; 2020 Aug; 55(8):1588-1594. PubMed ID: 32047286
[TBL] [Abstract][Full Text] [Related]
36. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
[TBL] [Abstract][Full Text] [Related]
37. Evaluating antimicrobial duration for Gram-negative bacteremia in patients with neutropenia due to hematologic malignancy or hematopoietic stem cell transplantation.
Ranganath N; Yetmar ZA; McCandless AR; Rivera CG; Lahr BD; Tande AJ; Shah AS
Transpl Infect Dis; 2023 Oct; 25(5):e14085. PubMed ID: 37279240
[TBL] [Abstract][Full Text] [Related]
38. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Antimicrobial Utilization among Cancer Patients with Febrile Neutropenia at the Lebanese Hospitals.
Cherri S; Malaeb D; Shouman L; Fahs I; Hallit R; Hallit S; Malaeb B; Salameh P
Curr Drug Saf; 2023; 18(4):496-503. PubMed ID: 35726429
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation.
Amini S; Hadjibabaie M; Jahangard-Rafsanjani Z; Ashuri A; Torkamandi H; Ghavamzadeh A
Acta Med Iran; 2014; 52(1):38-42. PubMed ID: 24658984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
